Medical Intensive Care Unit, University Hospital Leipzig, Leipzig, Germany
Case Report
Recognizing the Gap: A Case Series of Euglycemic and Hyperglycemic SGLT2 Inhibitor-Associated Diabetic Ketoacidosis
Author(s): Imke Schamarek*, Bastian Pasieka*, Michael Stumvoll, Thomas Ebert, Benjamin Sandner and Johannes Münch
Introduction: Ketoacidosis is a rare but serious side effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i), possibly overlooked in clinical practice. We aim to further characterize the presentation of and risk factors for SGLT2i-associated ketoacidosis to improve recognition in clinical practice.
Methods: Nine cases of diabetic patients identified with SGLT2i-associated ketoacidosis (DKA) at the University Hospital of Leipzig are presented in a case series.
Results: Euglycemia was detected in five out of nine cases. Symptoms varied, often remained unspecific and typical hallmark symptoms of ketoacidosis could not be identified in all cases. Four out of nine cases were female, and duration of diabetes disease and SGLT2i treatment, age and BMI showed a wide range. Risk factors most often identified were ca.. View more»